ID   DU #2
AC   CVCL_5528
SY   DU 2; DU-2
DR   BTO; BTO_0002944
DR   Wikidata; Q54831564
RX   PubMed=994214;
RX   PubMed=2624919;
CC   Doubling time: 44 hours (Note=At 61th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
RX   PubMed=994214; DOI=10.1093/jnci/56.6.1131;
RA   Giovanella, Beppino Carlo
RA   Stehlin, John Sebastian Jr.
RA   Santamaria, C.
RA   Yim, Sun Ock
RA   Morgan, Alton C. Jr.
RA   Williams, Leo J. Jr.
RA   Leibovitz, Albert
RA   Fialkow, Philip J.
RA   Mumford, David Meday
RT   "Human neoplastic and normal cells in tissue culture. I. Cell lines
RT   derived from malignant melanomas and normal melanocytes.";
RL   J. Natl. Cancer Inst. 56:1131-1142(1976).
//
RX   PubMed=2624919; DOI=10.1007/BF01744892; PMCID=PMC11038635;
RA   Guarini, Ludovico
RA   Temponi, Massimo
RA   Edwalds, Gretchen M.
RA   Vita, Joseph R.
RA   Fisher, Paul B.
RA   Ferrone, Soldano
RT   "In vitro differentiation and antigenic changes in human melanoma cell
RT   lines.";
RL   Cancer Immunol. Immunother. 30:262-268(1989).
//